IL-33/ST2 axis in inflammation and immunopathology

Immunologic Research

Volumn 52, Issue 1-2, 2012, Pages 89-99

  Milovanovic, Marija ^a   Volarevic, Vladislav ^a   Radosavljevic, Gordana ^a   Jovanovic, Ivan ^a   Pejnovic, Nada ^a   Arsenijevic, Nebojsa ^a   Lukic, Miodrag L ^a  

^a UNIVERSITY OF KRAGUJEVAC   (Serbia)

Author keywords

Con A hepatitis; EAE; IL 33 ST2 axis; MLD STZ diabetes; Mouse breast cancer

Indexed keywords

CONCANAVALIN A; CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 33; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BREAST CANCER; CANCER IMMUNOTHERAPY; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; ENZYME ACTIVATION; EXPERIMENTAL MODEL; GRANULOCYTE; GROWTH INHIBITION; HEPATITIS; HOST RESISTANCE; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOLOGY; INFECTION; INFLAMMATION; INJECTION; INSULIN DEPENDENT DIABETES MELLITUS; MAST CELL; MONOCYTE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; TUMOR GROWTH; TUMOR IMMUNOLOGY;

ANIMALS; APOPTOSIS; AUTOIMMUNITY; BREAST NEOPLASMS; DIABETES MELLITUS, TYPE 1; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HEPATITIS; HUMANS; INFLAMMATION; INTERLEUKINS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES;

EID: 84859917147     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-012-8283-9     Document Type: Article

References (97)

1. H Onda H Kasuya K Takakura T Hori T Imaizumi T Takeuchi I Inoue J Takeda 1999 Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage J Cereb Blood Flow Metab 19 11 1279 1288 10566975 10.1097/00004647-199911000-00013 1:CAS:528: DC%2BD3cXks1SntL0%3D
2. ES Baekkevold M Roussigné T Yamanaka FE Johansen FL Jahnsen F Amalric P Brandtzaeg M Erard G Haraldsen JP Girard 2003 Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules Am J Pathol 163 1 69 79 12819012 10.1016/S0002-9440(10) 63631-0 1:CAS:528:DC%2BD3sXmtVWrt7c%3D
3. S Tominaga NA Jenkins DJ Gilbert NG Copeland T Tetsuka 1991 Molecular cloning of the murine ST2 gene: characterization and chromosomal mapping Biochim Biophys Acta 1090 1 8 1832015 1:CAS:528:DyaK3MXmt1Giurw%3D
4. G Bergers A Reikerstorfer S Braselmann P Graninger M Busslinger 1994 Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor EMBO J 13 1176 1188 8131748 1:CAS:528:DyaK2cXktVagtLg%3D
5. K Oshikawa K Yanagisawa S Tominaga Y Sugiyama 2002 Expression and function of the ST2 gene in a murine model of allergic airway inflammation Clin Exp Allergy 32 10 1520 1526 12372135 10.1046/j.1365-2745.2002.01494.x 1:CAS:528:DC%2BD38XovVWgtrw%3D
6. K Kuroiwa T Arai H Okazaki S Minota S Tominaga 2001 Identification of human ST2 protein in the sera of patients with autoimmune diseases Biochem Biophys Res Commun 284 5 1104 1108 11414697 10.1006/bbrc.2001.5090 1:CAS:528:DC%2BD3MXksVKjsbc%3D
7. K Oshikawa K Kuroiwa K Tago H Iwahana K Yanagisawa S Ohno SI Tominaga Y Sugiyama 2001 Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation Am J Respir Crit Care Med 164 2 277 281 11463601 1:STN:280:DC%2BD3MvhsVShtg%3D%3D
8. S Tajima K Oshikawa S Tominaga Y Sugiyama 2003 The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis Chest 124 4 1206 1214 14555548 10.1378/chest.124.4.1206 1:CAS:528: DC%2BD3sXovF2hsr8%3D
9. EO Weinberg M Shimpo S Hurwitz S Tominaga JL Rouleau RT Lee 2003 Identification of serum soluble ST2 receptor as a novel heart failure biomarker Circulation 107 5 721 726 12578875 10.1161/01.CIR.0000047274.66749.FE
10. D Xu WL Chan BP Leung F Huang R Wheeler D Piedrafita JH Robinson FY Liew 1998 Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells J Exp Med 187 5 787 794 9480988 10.1084/jem.187.5.787 1:CAS:528:DyaK1cXhs1anurw%3D
11. J Schmitz A Owyang E Oldham Y Song E Murphy TK McClanahan G Zurawski M Moshrefi J Qin X Li DM Gorman JF Bazan RA Kastelein 2005 IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines Immunity 23 5 479 490 16286016 10.1016/j.immuni.2005.09.015 1:CAS:528:DC%2BD2MXht12msr7K
12. G Palmer BP Lipsky MD Smithgall D Meininger S Siu D Talabot-Ayer C Gabay DE Smith 2008 The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33 Cytokine 42 3 358 364 18450470 10.1016/j.cyto.2008.03.008 1:CAS:528: DC%2BD1cXms1Srt7k%3D
13. K Bulek S Swaidani J Qin Y Lu MF Gulen T Herjan B Min RA Kastelein M Aronica M Kosz-Vnenchak X Li 2009 The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response J Immunol 182 5 2601 2609 19234154 10.4049/jimmunol.0802729 1:CAS:528: DC%2BD1MXitFKhtrk%3D
14. PN Pushparaj HK Tay SC H'ng N Pitman D Xu A McKenzie FY Liew AJ Melendez 2009 The cytokine interleukin-33 mediates anaphylactic shock Proc Natl Acad Sci USA 106 24 9773 9778 19506243 10.1073/pnas.0901206106 1:CAS:528: DC%2BD1MXotFWqsrs%3D
15. Z Allakhverdi DE Smith MR Comeau G Delespesse 2007 Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells J Immunol 179 4 2051 2054 17675461 1:CAS:528:DC%2BD2sXosVyrur4%3D
16. D Moulin O Donzé D Talabot-Ayer F Mézin G Palmer C Gabay 2007 Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells Cytokine 40 3 216 225 18023358 10.1016/j.cyto.2007.09.013 1:CAS:528:DC%2BD2sXhsVSmu7rE
17. C Moussion N Ortega JP Girard 2008 The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS ONE 3 10 e3331 18836528 10.1371/journal.pone.0003331
18. T Ohno K Oboki H Morita N Kajiwara K Arae S Tanaka M Ikeda M Iikura T Akiyama J Inoue K Matsumoto K Sudo M Azuma K Okumura T Kamradt H Saito S Nakae 2011 Paracrine IL-33 stimulation enhances lipopolysaccharide-mediated macrophage activation PLoS ONE 6 4 e18404 21494550 10.1371/journal.pone.0018404 1:CAS:528:DC%2BC3MXltVWrtb0%3D
19. J Liu JM Buckley HP Redmond JH Wang 2010 ST2 negatively regulates TLR2 signaling, but is not required for bacterial lipoprotein-induced tolerance J Immunol 184 10 5802 5808 20400705 10.4049/jimmunol.0904127 1:CAS:528: DC%2BC3cXls1WisLc%3D
20. MJ Sweet BP Leung D Kang M Sogaard K Schulz V Trajkovic CC Campbell D Xu FY Liew 2001 A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression J Immunol 166 6633 6639 11359817 1:CAS:528:DC%2BD3MXjvFartbk%3D
21. S Kumar MN Tzimas DE Griswold PR Young 1997 Expression of ST2, an interleukin-1 receptor homologue, is induced by proinflammatory stimuli Biochem Biophys Res Commun 235 3 474 478 9207179 10.1006/bbrc.1997.6810 1:STN:280:DyaK2szltVyjsQ%3D%3D
22. D Talabot-Ayer C Lamacchia C Gabay G Palmer 2009 Interleukin-33 is biologically active independently of caspase-1 cleavage J Biol Chem 284 29 19420 19426 19465481 10.1074/jbc.M901744200 1:CAS:528:DC%2BD1MXot12kuro%3D
23. AU Lüthi SP Cullen EA McNeela PJ Duriez IS Afonina C Sheridan G Brumatti RC Taylor K Kersse P Vandenabeele EC Lavelle SJ Martin 2009 Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases Immunity 31 1 84 98 19559631 10.1016/j.immuni.2009.05.007
24. S Ali DQ Nguyen W Falk MU Martin 2010 Caspase 3 inactivates biologically active full length interleukin-33 as a classical cytokine but does not prohibit nuclear translocation Biochem Biophys Res Commun 391 3 1512 1516 20035719 10.1016/j.bbrc.2009.12.107 1:CAS:528:DC%2BC3cXot1ymtw%3D%3D
25. W Zhao Z Hu 2010 The enigmatic processing and secretion of interleukin-33 Cell Mol Immunol 7 4 260 262 20305685 10.1038/cmi.2010.3 1:CAS:528: DC%2BC3cXotlSmsro%3D
26. G Haraldsen J Balogh J Pollheimer J Sponheim AM Küchler 2009 Interleukin-33 - cytokine of dual function or novel alarmin? Trends Immunol 30 5 227 233 19359217 10.1016/j.it.2009.03.003 1:CAS:528:DC%2BD1MXlslWktrg%3D
27. V Carriere L Roussel N Ortega DA Lacorre L Americh L Aguilar G Bouche JP Girard 2007 IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo Proc Natl Acad Sci USA 104 1 282 287 17185418 10.1073/pnas.0606854104 1:CAS:528:DC%2BD2sXjt12msw%3D%3D
28. S Ali A Mohs M Thomas J Klare R Ross ML Schmitz MU Martin 2011 The dual function cytokine IL-33 interacts with the transcription factor NF-κB to dampen NF-κB-stimulated gene transcription J Immunol 187 4 1609 1616 21734074 10.4049/jimmunol.1003080 1:CAS:528:DC%2BC3MXpslOrt70%3D
29. M Enoksson K Lyberg C Möller-Westerberg PG Fallon G Nilsson C Lunderius-Andersson 2011 Mast cells as sensors of cell injury through IL-33 recognition J Immunol 186 4 2523 2528 21239713 10.4049/jimmunol.1003383 1:CAS:528:DC%2BC3MXhsVSgt78%3D
30. M Komai-Koma D Xu Y Li AN McKenzie IB McInnes FY Liew 2007 IL-33 is a chemoattractant for human Th2 cells Eur J Immunol 37 10 2779 2786 17853410 10.1002/eji.200737547 1:CAS:528:DC%2BD2sXht1ersrrI
31. MD Smithgall MR Comeau BR Yoon D Kaufman R Armitage DE Smith 2008 IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells Int Immunol 20 8 1019 1030 18550585 10.1093/intimm/dxn060 1:CAS:528:DC%2BD1cXptVenu7w%3D
32. E Bourgeois LP Van M Samson S Diem A Barra S Roga JM Gombert E Schneider M Dy P Gourdy JP Girard A Herbelin 2009 The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production Eur J Immunol 39 4 1046 1055 19266498 10.1002/eji.200838575 1:CAS:528: DC%2BD1MXltlamu7w%3D
33. M Kurowska-Stolarska B Stolarski P Kewin G Murphy CJ Corrigan S Ying, et al. 2009 IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation J Immunol 183 6469 6477 19841166 10.4049/jimmunol.0901575 1:CAS:528:DC%2BD1MXhtlKhsbfE
34. MA Rank T Kobayashi H Kozaki KR Bartemes DL Squillace H Kita 2009 IL-33-activated dendritic cells induce an atypical TH2-type response J Allergy Clin Immunol 123 5 1047 1054 19361843 10.1016/j.jaci.2009.02.026 1:CAS:528:DC%2BD1MXltlyitb8%3D
35. Q Yang G Li Y Zhu L Liu E Chen H Turnquist X Zhang OJ Finn X Chen B Lu 2011 IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8(+) T cells Eur J Immunol 41 11 3351 3360 21887788 10.1002/eji.201141629 1:CAS:528:DC%2BC3MXhtlGktbzL
36. AM Miller, et al. 2008 IL-33 reduces the development of atherosclerosis J Exp Med 205 339 346 18268038 10.1084/jem.20071868 1:CAS:528: DC%2BD1cXisVeht7c%3D
37. NE Humphreys D Xu MR Hepworth FY Liew RK Grencis 2008 IL-33, a potent inducer of adaptive immunity to intestinal nematodes J Immunol 180 4 2443 2449 18250453 1:CAS:528:DC%2BD1cXhsVShu7Y%3D
38. LA Jones F Roberts MB Nickdel F Brombacher AN McKenzie FL Henriquez J Alexander CW Roberts 2010 IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii Eur J Immunol 40 2 426 436 19950183 10.1002/eji.200939705 1:CAS:528: DC%2BC3cXhtlOiu70%3D
39. A Becerra RV Warke N de Bosch AL Rothman I Bosch 2008 Elevated levels of soluble ST2 protein in dengue virus infected patients Cytokine 41 2 114 120 18226917 10.1016/j.cyto.2007.11.001 1:CAS:528:DC%2BD1cXhsl2gtrk%3D
40. CA Hudson GP Christophi RC Gruber JR Wilmore DA Lawrence PT Massa 2008 Induction of IL-33 expression and activity in central nervous system glia J Leukoc Biol 84 3 631 643 18552204 10.1189/jlb.1207830 1:CAS:528: DC%2BD1cXhtV2itbjN
41. GA Roth M Zimmermann BA Lubsczyk J Pilz P Faybik H Hetz S Hacker A Mangold A Bacher CG Krenn HJ Ankersmit 2010 Up-regulation of interleukin 33 and soluble ST2 serum levels in liver failure J Surg Res 163 2 79 83 10.1016/j.jss.2010.04.004
42. X Xiao P Zhao D Rodriguez-Pinto D Qi O Henegariu L Alexopoulou A Flavell S Wong L Wen 2009 Inflammatory regulation by TLR3 in acute hepatitis J Immunol 183 3712 3719 19710451 10.4049/jimmunol.0901221 1:CAS:528:DC%2BD1MXhtVOmurnO
43. A Itoh K Isoda M Kondoh M Kawase M Kobayashi M Tamesada K Yagi 2009 Hepatoprotective effect of syringic acid and vanillic acid on concanavalin a-induced liver injury Biol Pharm Bull 32 1215 1219 19571388 10.1248/bpb.32.1215 1:CAS:528:DC%2BD1MXhtVGhur7M
44. AM Wolf D Wolf MA Avila AR Moschen C Berasain B Enrich H Rumpold H Tilg 2006 Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in mice J Hepatol 44 537 543 16310276 10.1016/j.jhep.2005.08.019 1:CAS:528:DC%2BD28XhsFKktr8%3D
45. JC Hanson MK Bostick CB Campe P Kodali G Lee J Yan JJ Maher 2006 Transgenic overexpression of interleukin-8 in mouse liver protects against galactosamine/endotoxin toxicity J Hepatol 44 359 567 16168518 10.1016/j.jhep.2005.06.022 1:CAS:528:DC%2BD28XksVSjsw%3D%3D
46. G Tiegs J Hentschel A Wendel 1992 A T cell-dependent experimental liver injury in mice inducible by concanavalin A J Clin Invest 90 196 203 1634608 10.1172/JCI115836 1:CAS:528:DyaK38XltVGqtrw%3D
47. Volarevic V, Mitrovic M, Milovanovic M, Zelen I, Nikolic I, Mitrovic S, Pejnovic N, Arsenijevic N, Lukic ML. Protective role of IL-33/ST2 axis in Con A-induced hepatitis. J Hepatol. 2012;56(1):26-33.
48. A Erhardt M Biburger T Papadopoulos G Tiegs 2007 IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice Hepatology 45 2 475 485 17256743 10.1002/hep.21498 1:CAS:528:DC%2BD2sXisVKns78%3D
49. HX Wei YH Chuang B Li H Wei R Sun Y Moritoki ME Gershwin ZX Lian Z Tian 2008 CD4 + CD25 + Foxp3 + regulatory T cells protect against T cell-mediated fulminant hepatitis in a TGF-beta-dependent manner in mice J Immunol 181 10 7221 7229 18981144 1:CAS:528:DC%2BD1cXhtlaisrjJ
50. T Nagata L Mckinley J Peschon J Alcorn S Aujla J Kolls 2008 Requirement of IL-17RA in Con A induced hepatitis and negative regulation of IL-17 production in mouse T cells J Immunol 181 7473 7479 19017936 1:CAS:528:DC%2BD1cXhtl2gs7nP
51. M Suzuki K Maghni S Molet A Shimbara QA Hamid JG Martin 2002 IFN-gamma secretion by CD8T cells inhibits allergen-induced airway eosinophilia but not late airway responses J Allergy Clin Immunol 109 803 809 11994704 10.1067/mai.2002.123233 1:CAS:528:DC%2BD38XksFSqsbs%3D
52. Z Dong H Wei R Sun Z Tian 2007 The roles of innate immune cells in liver injury and regeneration Cell Mol Immunol 4 241 252 17764614 1:CAS:528: DC%2BD2sXhtFGqtbrM
53. K Takeda Y Hayakawa L Van Kaer H Matsuda H Yagita K Okumura 2000 Critical contribution of liver natural killer T cells to a murine model of hepatitis Proc Natl Acad Sci USA 97 5498 5503 10792025 10.1073/pnas.040566697 1:CAS:528:DC%2BD3cXjsVWms78%3D
54. S Küsters F Gantner G Kunstle G Tiegs 1996 Interferon gamma plays a critical role in T cell dependent liver injury in mice initiated by concanavalin A Gastroenterology 111 462 471 8690213 10.1053/gast.1996.v111.pm8690213
55. R Robinson J Wang J Cripps M Milks K English T Pearson J Gorham 2009 End-organ damage in a mouse model of fulminant liver inflammation requires CD4 + T cell production of IFN-γ but is independent of Fas J Immunol 182 3278 3284 19234226 10.4049/jimmunol.0803417 1:CAS:528:DC%2BD1MXitFKgsLw%3D
56. Y Tagawa K Sekikawa Y Iwakura 1997 Suppression of concanavalin A-induced hepatitis in IFN-γ -/- mice, but not in TNF-α -/- mice: role for IFN-γ in activating apoptosis of hepatocytes J Immunol 159 1418 1428 9233639 1:CAS:528:DyaK2sXkslKktb0%3D
57. LA Zenewicz GD Yancopoulos DM Valenzuela A Murphy M Karow RA Flavell 2007 Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation Immunity 27 647 659 17919941 10.1016/j.immuni.2007.07. 023 1:CAS:528:DC%2BD2sXht1ygurzK
58. Z Wondimu T Santodomingo-Garzon T Le MG Swain 2010 Protective role of interleukin-17 in murine NKT cell-driven acute experimental hepatitis Am J Pathol 177 2334 2346 20847291 10.2353/ajpath.2010.100028 1:CAS:528: DC%2BC3cXhsFWgsr7J
59. M Xu N Morishima I Mizoguchi Y Chiba K Fujita M Kuroda Y Iwakura DJ Cua K Yasutomo J Mizuguchi T Yoshimoto 2011 Regulation of the development of acute hepatitis by IL-23 through IL-22 and IL-17 production Eur J Immunol 41 10 2828 2839 21953641 10.1002/eji.201141291 1:CAS:528:DC%2BC3MXht1Srs7zF
60. Erhardt A, Tiegs G. IL-33-a cytokine which balances on a knife's edge? J Hepatol. 2012;56(1):7-10.
61. FY Liew NI Pitman IB McInnes 2010 Disease-associated functions of IL-33: the new kid in the IL-1 family Nat Rev Immunol 10 2 103 110 20081870 10.1038/nri2692 1:CAS:528:DC%2BC3cXntVCrtg%3D%3D
62. K Oboki S Nakae K Matsumoto H Saito 2011 IL-33 and airway inflammation Allergy Asthma Immunol Res 3 2 81 88 21461246 10.4168/aair.2011.3.2.81 1:CAS:528:DC%2BC3MXlt1Whsr4%3D
63. D Préfontaine S Lajoie-Kadoch S Foley S Audusseau R Olivenstein AJ Halayko C Lemière JG Martin Q Hamid 2009 Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells J Immunol 183 8 5094 5103 19801525 10.4049/jimmunol.0802387
64. J Kearley KF Buckland SA Mathie CM Lloyd 2009 Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway Am J Respir Crit Care Med 179 9 772 781 19179489 10.1164/rccm.200805-666OC 1:CAS:528:DC%2BD1MXmtFeitbc%3D
65. H Hayakawa M Hayakawa A Kume S Tominaga 2007 Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation J Biol Chem 282 26369 26380 17623648 10.1074/jbc.M704916200 1:CAS:528:DC%2BD2sXpslGjt7s%3D
66. D Préfontaine J Nadigel F Chouiali S Audusseau A Semlali J Chakir JG Martin Q Hamid 2010 Increased IL-33 expression by epithelial cells in bronchial asthma J Allergy Clin Immunol 125 3 752 754 20153038 10.1016/j.jaci.2009.12.935
67. Y Kondo T Yoshimoto K Yasuda S Futatsugi-Yumikura M Morimoto N Hayashi T Hoshino J Fujimoto K Nakanishi 2008 Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system Int Immunol 20 6 791 800 18448455 10.1093/intimm/dxn037 1:CAS:528:DC%2BD1cXmsFOitL8%3D
68. B Stolarski M Kurowska-Stolarska P Kewin D Xu FY Liew 2010 IL-33 exacerbates eosinophil-mediated airway inflammation J Immunol 185 6 3472 3480 20693421 10.4049/jimmunol.1000730 1:CAS:528:DC%2BC3cXhtFSntL3E
69. X Zhiguang C Wei R Steven D Wei Z Wei M Rong L Zhanguo Z Lianfeng 2010 Over-expression of IL-33 leads to spontaneous pulmonary inflammation in mIL-33 transgenic mice Immunol Lett 131 2 159 165 20412815 10.1016/j.imlet.2010.04.005
70. AG Besnard D Togbe N Guillou F Erard V Quesniaux B Ryffel 2011 IL-33-activated dendritic cells are critical for allergic airway inflammation Eur J Immunol 41 6 1675 1686 21469105 10.1002/eji.201041033 1:CAS:528: DC%2BC3MXmsFGis7o%3D
71. K Oboki T Ohno N Kajiwara K Arae H Morita A Ishii A Nambu T Abe H Kiyonari K Matsumoto K Sudo K Okumura H Saito S Nakae 2010 IL-33 is a crucial amplifier of innate rather than acquired immunity Proc Natl Acad Sci USA 107 43 18581 18586 20937871 10.1073/pnas.1003059107 1:CAS:528:DC%2BC3cXhtl2ktrvF
72. AJ Coyle C Lloyd J Tian T Nguyen C Erikkson L Wang P Ottoson P Persson T Delaney S Lehar S Lin L Poisson C Meisel T Kamradt T Bjerke D Levinson JC Gutierrez-Ramos 1999 Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses J Exp Med 190 7 895 902 10510079 10.1084/jem.190.7.895 1:CAS:528:DyaK1MXmsVCltrs%3D
73. M Kurowska-Stolarska P Kewin G Murphy RC Russo B Stolarski CC Garcia M Komai-Koma N Pitman Y Li W Niedbala AN McKenzie MM Teixeira FY Liew D Xu 2008 IL-33 induces antigen-specific IL-5 + T cells and promotes allergic-induced airway inflammation independent of IL-4 J Immunol 181 7 4780 4790 18802081 1:CAS:528:DC%2BD1cXhtFarurvK
74. NE Mangan A Dasvarma AN McKenzie PG Fallon 2007 T1/ST2 expression on Th2 cells negatively regulates allergic pulmonary inflammation Eur J Immunol 37 5 1302 1312 17407196 10.1002/eji.200636520 1:CAS:528:DC%2BD2sXls1yjs70%3D
75. H Wesche C Korherr M Kracht W Falk K Resch MU Martin 1997 The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases) J Biol Chem 272 12 7727 7731 9065432 10.1074/jbc.272.12.7727 1:CAS:528:DyaK2sXitFWgtbc%3D
76. N Zdravkovic A Shahin N Arsenijevic ML Lukic EP Mensah-Brown 2009 Regulatory T cells and ST2 signaling control diabetes induction with multiple low doses of streptozotocin Mol Immunol 47 1 28 36 19356801 10.1016/j.molimm. 2008.12.023 1:CAS:528:DC%2BD1MXhtleksb3L
77. HR Jiang Z Al Rasebi E Mensah-Brown, et al. 2009 Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis J Immunol 182 2 1167 1173 19124760 1:CAS:528:DC%2BD1MXhsVKrsg%3D%3D
78. H Nakano KL Lin M Yanagita C Charbonneau DN Cook T Kakiuchi MD Gunn 2009 Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses Nat Immunol 10 4 394 402 19252492 10.1038/ni.1707 1:CAS:528:DC%2BD1MXisVOrt78%3D
79. DS Vinay CH Kim BK Choi BS Kwon 2009 Origins and functional basis of regulatory CD11c + CD8 + T cells Eur J Immunol 39 6 1552 1563 19499519 10.1002/eji.200839057 1:CAS:528:DC%2BD1MXntFCitLk%3D
80. I Jovanovic G Radosavljevic M Mitrovic VL Juranic AN McKenzie N Arsenijevic S Jonjic ML Lukic 2011 ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma Eur J Immunol 41 7 1902 1912 21484786 10.1002/eji.201141417 1:CAS:528:DC%2BC3MXnvF2gtrk%3D
81. M Foti F Granucci P Ricciardi-Castagnoli 2004 A central role for tissue-resident dendritic cells in innate responses Trends Immunol 25 12 650 654 15530834 10.1016/j.it.2004.10.007 1:CAS:528:DC%2BD2cXptl2ktLo%3D
82. N Mayuzumi H Matsushima A Takashima 2009 IL-33 promotes DC development in BM culture by triggering GM-CSF production Eur J Immunol 39 12 3331 3342 19750479 10.1002/eji.200939472 1:CAS:528:DC%2BD1MXhsFaku7%2FI
83. A Mantovani S Sozzani M Locati P Allavena A Sica 2002 Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes Trends Immunol 23 549 555 12401408 10.1016/S1471-4906(02) 02302-5 1:CAS:528:DC%2BD38XotVKktrc%3D
84. S Gordon PR Taylor 2005 Monocyte and macrophage heterogeneity Nat Rev Immunol 5 953 964 16322748 10.1038/nri1733 1:CAS:528:DC%2BD2MXht1Kntr3N
85. A Mantovani A Sica M Locati 2005 Macrophage polarization comes of age Immunity 23 344 346 16226499 10.1016/j.immuni.2005.10.001 1:CAS:528: DC%2BD2MXht1Shs77O
86. FO Martinez L Helming S Gordon 2009 Alternative activation of macrophages: an immunologic functional perspective Annu Rev Immunol 27 451 483 19105661 10.1146/annurev.immunol.021908.132532 1:CAS:528:DC%2BD1MXlsFSltrk%3D
87. FA Verreck T de Boer DM Langenberg MA Hoeve M Kramer E Vaisberg R Kastelein A Kolk R de Waal-Malefyt TH Ottenhoff 2004 Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria Proc Natl Acad Sci USA 101 4560 4565 15070757 10.1073/pnas.0400983101 1:CAS:528:DC%2BD2cXjtFKis70%3D
88. A Mantovani A Sica M Locati 2007 New vistas on macrophage differentiation and activation Eur J Immunol 37 14 16 17183610 10.1002/eji.200636910 1:CAS:528:DC%2BD2sXhtFGitrk%3D
89. G Solinas G Germano A Mantovani P Allavena 2009 Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation J Leukoc Biol 86 1065 1073 19741157 10.1189/jlb.0609385 1:CAS:528:DC%2BD1MXhtlyjs7vL
90. RD Stout SK Watkins J Suttles 2009 Functional plasticity of macrophages: in situ reprogramming of tumor-associated macrophages J Leukoc Biol 86 1105 1109 19605698 10.1189/jlb.0209073 1:CAS:528:DC%2BD1MXhtlyjs7jN
91. JW Pollard 2009 Trophic macrophages in development and disease Nat Rev Immunol 9 259 270 19282852 10.1038/nri2528 1:CAS:528:DC%2BD1MXjtFCisbc%3D
92. A Mantovani P Allavena A Sica 2004 Tumor-associated macrophages as a prototypic type II polarized phagocyte population: role in tumor progression Eur J Cancer 40 1660 1667 15251154 10.1016/j.ejca.2004.03.016 1:CAS:528: DC%2BD2cXls1Wntr4%3D
93. Jovanovic I, Pejnovic N, Radosavljevic G, Arsenijevic N, Lukic ML. IL-33/ST2 Axis in innate and acquired immunity to tumors. Oncoimmunology. 2012;1:229-31.
94. G Palmer D Talabot-Ayer C Lamacchia D Toy CA Seemayer S Viatte A Finckh DE Smith C Gabay 2009 Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis Arthritis Rheum 60 3 738 749 19248109 10.1002/art.24305 1:CAS:528:DC%2BD1MXktVGmsLg%3D
95. H Ohto-Ozaki K Kuroiwa N Mato Y Matsuyama M Hayakawa H Tamemoto S Tominaga 2010 Characterization of ST2 transgenic mice with resistance to IL-33 Eur J Immunol 40 9 2632 2642 20662097 10.1002/eji.200940291 1:CAS:528: DC%2BC3cXhtV2gurfJ
96. L Pastorelli RR Garg SB Hoang L Spina B Mattioli M Scarpa C Fiocchi M Vecchi TT Pizarro 2010 Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis Proc Natl Acad Sci USA 107 17 8017 8022 20385815 10.1073/pnas.0912678107 1:CAS:528:DC%2BC3cXlsF2qu7c%3D
97. H Yin XY Li BH Yuan BB Zhang SL Hu HB Gu XB Jin JY Zhu 2011 Adenovirus-mediated overexpression of soluble ST2 provides a protective effect on lipopolysaccharide-induced acute lung injury in mice Clin Exp Immunol 164 2 248 255 21352201 10.1111/j.1365-2249.2011.04326.x 1:CAS:528:DC%2BC3MXntVCmtrg%3D